Healthcare costs and quality of life outcomes following gender affirming surgery in trans men: a review [0.03%]
男性跨性别者的性别确认手术后的医疗费用和生活质量结局:综述
Justine Defreyne,Joz Motmans,Guy Tsjoen
Justine Defreyne
Options for gender affirming therapy in trans men include social transitioning, mental coaching, hormonal therapy and gender affirming surgery. Research has concluded that gender affirming therapy is safe and feasible and generally leads to...
Cost-effectiveness of pertuzumab combined with trastuzumab and docetaxel as a first-line treatment for HER-2 positive metastatic breast cancer [0.03%]
帕博珠单抗联合曲妥珠单抗和多西他赛作为HER-2阳性转移性乳腺癌一线治疗的疗效成本分析
Henry W C Leung,Agnes L F Chan,Chih-Hsin Muo et al.
Henry W C Leung et al.
Objective: To provide perspective for the National Health Insurance Bureau (NHIB), we determined the cost-effectiveness of pertuzumab combined with trastuzumab and docetaxel (TDP) versus trastuzumab and docetaxel (TD) as ...
Trends and determinants in reimbursement decision-making in Poland in the years 2013-2015 [0.03%]
波兰2013至2015年医保报销决策趋势及影响因素分析
Paweł Kawalec,Krzysztof Piotr Malinowski,Wojciech Trąbka
Paweł Kawalec
Objective: To assess changes in the involvement of advisory bodies in the reimbursement decision-making process in Poland, and to evaluate variables that influenced HTA recommendations in the years 2013-2015. ...
Ann M Moyer,Pedro J Caraballo
Ann M Moyer
Pharmacogenomic testing has the potential to greatly benefit patients by enabling personalization of medication management, ensuring better efficacy and decreasing the risk of side effects. However, to fully realize the potential of pharmac...
The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia [0.03%]
医疗卫生决策中的创新价值——医疗保健创新决策第六国际会议,2017年6月2日,塞尔维亚贝尔格莱德
Tanja Novakovic,Antony P Martin,Mark Parker et al.
Tanja Novakovic et al.
The Pharmacoeconomics Section of the Pharmaceutical Association of Serbia organised a one day international conference on the value of innovation in decision-making in health care in Central and Eastern Europe. The focus of the conference w...
Applying stated-preference methods to improve health systems in sub-Saharan Africa: a systematic review [0.03%]
应用于非洲撒哈拉以南地区卫生系统的声明偏好法的系统性综述
Lauren Brown,Ting-Hsuan Lee,Manuela De Allegri et al.
Lauren Brown et al.
Sub-Saharan African health systems must balance shifting disease burdens with desires for robust institutions. Stated-preference methods have been applied extensively to elicit health care workers' preferences and priorities for rural pract...
Athanasios Dellis,Athanasios Papatsoris
Athanasios Dellis
Recently, LHRH antagonists have been established in the management of advanced prostate cancer, although the vast majority of Medical Oncologists and Urologists still prefer the LHRH agonists. Areas Covered: In this article we assess the th...
Best-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austria [0.03%]
最佳-最差尺度评估奥地利卫生技术评估应用最重要的障碍和促进因素
Chiara Feig,Kei Long Cheung,Mickaël Hiligsmann et al.
Chiara Feig et al.
Background: Although Health Technology Assessment (HTA) is increasingly used to support evidence-based decision-making in health care, several barriers and facilitators for the use of HTA have been identified. This best-w...
The projected public health and economic impact of vitamin D fortified dairy products for fracture prevention in France [0.03%]
法国通过维生素D强化乳制品进行骨折预防的预计公共卫生及经济影响
Mickael Hiligsmann,Jean-Yves Reginster
Mickael Hiligsmann
Background: There is a paucity of research that projects the public health and economic impact of healthcare interventions in the future. In this study, we aimed to estimate the public health and economic impact of vitami...
Economic evaluation of pharmacist-led medication reviews in residential aged care facilities [0.03%]
关于老年护理机构中基于药剂师的药物回顾的经济评估研究
Syed Shahzad Hasan,Kaeshaelya Thiruchelvam,Chia Siang Kow et al.
Syed Shahzad Hasan et al.
Medication reviews is a widely accepted approach known to have a substantial impact on patients' pharmacotherapy and safety. Numerous options to optimise pharmacotherapy in older people have been reported in literature and they include medi...